Phillip Needleman - Publications

Washington University School of Medicine, St. Louis, MO, United States 
prostaglandins, cyclooxygenase, COX inhibitors

29 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
1992 Breder CD, Smith WL, Raz A, Masferrer J, Seibert K, Needleman P, Saper CB. Distribution and characterization of cyclooxygenase immunoreactivity in the ovine brain. The Journal of Comparative Neurology. 322: 409-38. PMID 1517485 DOI: 10.1002/cne.903220309  0.455
1991 Spencer SE, Kibbe MR, Hurley KM, Needleman P, Saper CB. Origin of porcine brain natriuretic peptide-like immunoreactive innervation of the middle cerebral artery in the rat. Neuroscience Letters. 128: 217-20. PMID 1834966 DOI: 10.1016/0304-3940(91)90264-T  0.452
1990 Saper CB, Kibbe MR, Hurley KM, Spencer S, Holmes HR, Leahy KM, Needleman P. Brain natriuretic peptide-like immunoreactive innervation of the cardiovascular and cerebrovascular systems in the rat. Circulation Research. 67: 1345-54. PMID 1978807 DOI: 10.1161/01.Res.67.6.1345  0.469
1989 Needleman P, Blaine EH, Greenwald JE, Michener ML, Saper CB, Stockmann PT, Tolunay HE. The biochemical pharmacology of atrial peptides. Annual Review of Pharmacology and Toxicology. 29: 23-54. PMID 2524996 DOI: 10.1146/  0.428
1989 Saper CB, Hurley KM, Moga MM, Holmes HR, Adams SA, Leahy KM, Needleman P. Brain natriuretic peptides: differential localization of a new family of neuropeptides. Neuroscience Letters. 96: 29-34. PMID 2522605 DOI: 10.1016/0304-3940(89)90238-3  0.447
1988 Standaert DG, Needleman P, Day ML, Weigand R, Krause JE. Expression of the gene for preproatriopeptin in the central nervous system of the rat. Brain Research. 464: 7-13. PMID 2460196 DOI: 10.1016/0169-328X(88)90012-5  0.506
1987 Standaert DG, Cechetto DF, Needleman P, Saper CB. Inhibition of the firing of vasopressin neurons by atriopeptin. Nature. 329: 151-3. PMID 2957595 DOI: 10.1038/329151a0  0.604
1987 Day ML, Schwartz D, Wiegand RC, Stockman PT, Brunnert SR, Tolunay HE, Currie MG, Standaert DG, Needleman P. Ventricular atriopeptin. Unmasking of messenger RNA and peptide synthesis by hypertrophy or dexamethasone. Hypertension. 9: 485-91. PMID 2952591 DOI: 10.1161/01.Hyp.9.5.485  0.453
1986 Standaert DG, Needleman P, Saper CB. Organization of atriopeptin-like immunoreactive neurons in the central nervous system of the rat. The Journal of Comparative Neurology. 253: 315-41. PMID 2947936 DOI: 10.1002/cne.902530304  0.582
1985 Needleman P, Adams SP, Cole BR, Currie MG, Geller DM, Michener ML, Saper CB, Schwartz D, Standaert DG. Atriopeptins as cardiac hormones. Hypertension. 7: 469-82. PMID 2989170 DOI: 10.1161/01.Hyp.7.4.469  0.535
1985 Saper CB, Standaert DG, Currie MG, Schwartz D, Geller DM, Needleman P. Atriopeptin-immunoreactive neurons in the brain: presence in cardiovascular regulatory areas. Science (New York, N.Y.). 227: 1047-9. PMID 2858127 DOI: 10.1126/science.2858127  0.584
1976 Douglas JR, Johnson EM, Heist JF, Marshall GR, Needleman P. Is the peripheral sympatho-adrenal nervous system necessary for renal hypertension? The Journal of Pharmacology and Experimental Therapeutics. 196: 35-43. PMID 1246014  0.428
1975 Douglas JR, Johnson EM, Marshall GR, Heist J, Hartman BK, Needleman P. Development and maintenance of renal hypertension in normal and guanethidine sympathectomized rats. Circulation Research. 36: 171-8. PMID 1093753 DOI: 10.1161/01.Res.36.6.171  0.439
1974 Johnson EM, Marshall GR, Needleman P. Modification of responses to sympathetic nerve stimulation by the renin-angiotensin system in rats. British Journal of Pharmacology. 51: 541-7. PMID 4375530 DOI: 10.1111/J.1476-5381.1974.Tb09672.X  0.434
1974 Needleman P, Marshall GR, Johnson EM. Determinants and modification of adrenergic and vascular resistance in the kidney. The American Journal of Physiology. 227: 665-9. PMID 4369912 DOI: 10.1152/ajplegacy.1974.227.3.665  0.364
1974 Needleman P, Douglas JR, Jakschik B, Stoecklein PB, Johnson EM. Release of renal prostaglandin by catecholamines: relationship to renal endocrine function. The Journal of Pharmacology and Experimental Therapeutics. 188: 453-60. PMID 4359555  0.401
1973 Ferrendelli JA, Johnson EM, Chang M, Needleman P. Inhibition of brain adenylate cyclase by ethacrynic acid and dithiobisnitrobenzoic acid. Biochemical Pharmacology. 22: 3133-6. PMID 4761572 DOI: 10.1016/0006-2952(73)90206-2  0.363
1973 Johnson EM, Lang S, Needleman P. Dissociation of sympathetic compensation from glyceryl trinitrate tolerance. European Journal of Pharmacology. 21: 189-94. PMID 4633119 DOI: 10.1016/0014-2999(73)90225-2  0.389
1973 Needleman P, Johnson EM. Mechanism of tolerance development to organic nitrates. The Journal of Pharmacology and Experimental Therapeutics. 184: 709-15. PMID 4631470  0.342
1973 Needleman P, Kauffman AH, Douglas JR, Johnson EM, Marshall GR. Specific stimulation and inhibition of renal prostaglandin release by angiotensin analogs. The American Journal of Physiology. 224: 1415-9. PMID 4351298 DOI: 10.1152/ajplegacy.1973.224.6.1415  0.409
1973 Douglas JR, Johnson EM, Marshall GR, Jaffe BM, Needleman P. Stimulation of splenic prostaglandin release by angiotensin and specific inhibition by cysteine 8-AII. Prostaglandins. 3: 67-74. PMID 4348364 DOI: 10.1016/0090-6980(73)90138-X  0.391
1973 Needleman P, Jakschik B, Johnson EM. Sulfhydryl requirement for relaxation of vascular smooth muscle. The Journal of Pharmacology and Experimental Therapeutics. 187: 324-31. PMID 4201275  0.328
1972 Johnson EM, Harkey AB, Blehm DJ, Needleman P. Clearance and metabolism of organic nitrates. The Journal of Pharmacology and Experimental Therapeutics. 182: 56-62. PMID 4625289  0.364
1972 Needleman P, Lang S, Johnson EM. Organic nitrates: relationship between biotransformation and rational angina pectoris therapy. The Journal of Pharmacology and Experimental Therapeutics. 181: 489-97. PMID 4624401  0.34
1972 Lang S, Johnson EM, Needleman P. Metabolism of and vascular responses to glyceryl trinitrate in the eviscerated rat. Biochemical Pharmacology. 21: 422-4. PMID 4622561 DOI: 10.1016/0006-2952(72)90356-5  0.404
1972 Blaustein MP, Johnson EM, Needleman P. Calcium-dependent norepinephrine release from presynaptic nerve endings in vitro. Proceedings of the National Academy of Sciences of the United States of America. 69: 2237-40. PMID 4506092 DOI: 10.1073/Pnas.69.8.2237  0.366
1972 Needleman P, Johnson EM, Vine W, Flanigan E, Marshall GR. Pharmacology of antagonists of angiotensin I and II. Circulation Research. 31: 862-7. PMID 4345101 DOI: 10.1161/01.Res.31.6.862  0.356
1971 Needleman P, Blehm DJ, Harkey AB, Johnson EM, Lang S. The metabolic pathway in the degradation of glyceryl trinitrate. The Journal of Pharmacology and Experimental Therapeutics. 179: 347-53. PMID 5002725  0.345
1968 Needleman P, Passonneau JV, Lowry OH. Distribution of glucose and related metabolites in rat kidney. The American Journal of Physiology. 215: 655-9. PMID 5671004 DOI: 10.1152/ajplegacy.1968.215.3.655  0.46
Show low-probability matches.